Table 2.
Baseline characteristics of the new atrial fibrillation patients at the time of entry to the study cohort between years 2012 and 2018
| n (%, of the total 178,253 patients) | |
|---|---|
| Female | 87,165 (49%) |
| Age, mean (± SD), median; years | 73.7 (± 12.6), 75 |
| Age ≥ 65 years | 140,093 (79%) |
| Age ≥ 75 years | 89,860 (50%) |
| Hypertension | 146,115 (82%) |
| Diabetes | 44,171 (25%) |
| Stroke or TIA | 30,312 (17%) |
| Heart failure | 32,627 (18%) |
| Vascular diseasea | 51,080 (29%) |
| Hyperlipidemia | 96,834 (54%) |
| CHA2DS2-VASc, mean (± SD), median | 3.8 (± 1.8), 4 |
TIA, transient ischemic attack
aCoronary artery disease or peripheral artery disease. CHA2DS2-VASc: congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, stroke, vascular disease, age 65–74 years, sex category (female)